Screener by Innerkore

Torrent Pharmaceuticals Limited

NSE: TORNTPHARMBSE: 500420HealthcarePharmaceuticals & Biotechnology

Torrent Pharmaceuticals Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: TORNTPHARM and BSE: 500420 (ISIN INE685A01028).

It has a market capitalisation of ₹1.54 lakh crore, a last close of ₹4,559 on 2026-10-19, a one-year return of 27.2%.

Valuation: a price-to-earnings ratio of 70.65x, a price-to-book ratio of 18.37x, a dividend yield of 0.8%.

Profitability: return on equity of 27.1%, return on capital employed of 14.1%, an operating margin of 33.0%.

Growth: sales growth of 13.3% a year over three years, net profit growth of 20.2% a year over three years.

Balance sheet and ownership: debt-to-equity of 1.76x, promoter holding of 60.8%.

Key figures for TORNTPHARM, prices as of 2026-10-19
MetricValue
Market capitalisation1.54 L Cr
Last close₹4,559
P/E (TTM)70.65x
P/B18.37x
Dividend yield0.8%
ROE (FY)27.1%
ROCE (FY)14.1%
Operating margin (TTM)33.0%
Sales growth, 3-year CAGR13.3%
Profit growth, 3-year CAGR20.2%
Debt / equity1.76x
Promoter holding60.8%
1-year return27.2%

Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means